Seqirus Awarded U.S. Government Contract to Develop Two Pandemic Influenza Vaccines Read Release Seqirus Invests in Next-Generation Influenza Vaccine Technology, Self-Amplifying Messenger RNA (sa-mRNA) NEJM Publishes Study on Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) Efficacy in Children and Adolescents Our Response to COVID-19 Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, we have remained steadfast in our promise to safeguard public health. As the pandemic continues to evolve, so have we. We have redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. We're committed to the fight against influenza At Seqirus, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza vaccines help protect millions of people. We find solutions to big, complex, challenging problems, and we see the results in the world around us. Then we do it all over again the following year. Seqirus is one of the world’s largest influenza vaccine companies. We were created when our parent company, CSL Limited, acquired the Novartis influenza vaccine business and combined it with vaccine subsidiary, bioCSL. More than 100 years of securing healthy lives Seqirus has a rich heritage in guarding against influenza. As part of CSL, our experience dates back to the deadly 1918 influenza pandemic and we’ve worked with global health partners on the front line of influenza protection ever since. Learn more Join us on the front line When you join Seqirus, you join a skilled and passionate team dedicated to protecting people and communities from influenza. It's the feeling of purpose and possibility that inspires us every day. Careers This website is intended for people seeking information on Seqirus' worldwide business. Our country sites can be located in our Worldwide Directory. GBR-FLU-0006 February 2021 Our Company We are one of the world’s largest influenza vaccine companies with a unique singular focus on influenza. Learn more Products Our broad range of influenza vaccines help safeguard people and communities all around the globe. Learn more Contact There are many ways to contact us and connect to our offices around the world. Learn more Report an Adverse Event Cookie Policy Privacy Notice Modern Slavery Terms of Use Sitemap © 2021 Seqirus. All rights reserved. Seqirus is a trademark of Seqirus UK Limited or its affiliates. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies